Comparisons across the whole retina revealed both genotype- and treatment-associated differences; Brn3a+ cell density was significantly lower in SAL-treated KO rats relative to WT rats, confirming the vulnerability of this population in WS (Figures 4F, G). This evidence concerns the gene POU4F1 and Werner syndrome.